Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and the leading cause of cancer-related death worldwide. One critical factor that makes treating colon cancer challenging is the presence of cancer stem cells. Subscribe to our newsletter for the latest sci-tech news updates. Though typically present in small populations, these powerful cells drive tumor growth, resist standard treatments, and often contribute to relapse. They achieve this through their “stemness,” a set of properties that enable these cells to self-renew and differentiate into other cell types. Thus, understanding how stemness might be controlled at the…
Penulis: beny13
The South Carolina Law Enforcement Division (SLED) charged a woman with insurance fraud on Friday.Shameka Reanda Delane, 44, was charged with making a false statement or misrepresentation, according to a release from SLED. Officials said this was her first offense.On Nov. 28, 2022, Delane opened a Geico Insurance account policy with claims involving someone who had passed away more than 10 months prior, according to an arrest warrant.The warrant said three claims were filed under the policy, with a total amount of $80,726.65.READ NEXT: Stabbing reported outside Florence apartment complexDelane said she opened the account for a better policy rate,…
Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor Jukka Westermarck, have developed a diagnostic tool that can revolutionize the treatment guidance of head and neck squamous cell carcinoma. Subscribe to our newsletter for the latest sci-tech news updates. Their study, recently published in EMBO Molecular Medicine, introduces an easy-to-use immunohistochemical assay for detecting the LIMA1-alpha protein, which reliably predicts whether patients can be cured with surgery alone—avoiding the need for harmful oncological treatments. Surgery remains a cornerstone in the treatment of solid tumors, including head and neck squamous cell carcinoma.…
Fact checked by Betsy PetrickLife insurance helps support your loved ones financially if you die, but some causes of death, like suicide, committing a crime, or engaging in dangerous sports, might not be covered. It’s important to read your policy carefully to know what could affect the payout.Life Insurance Exclusions: What’s Not Covered?Exclusions are conditions in life insurance contracts that prevent the insurance company from paying out the death benefit to your beneficiary(s). These excluded situations may be listed in the conditions, definitions, or fine print of the insurer’s contract.To ensure you get the most out of your insurance policy…
READ MORE: Experts pinpoint reason for surge of cancer in young peopleA ‘fit and healthy’ father received a devastating cancer diagnosis after a bizarre symptom triggered a trip to the doctors—a lasting smell of caramel.Stoke-on-Trent chip shop owner Costas Fantis, 57, knew something was wrong when once a month he kept smelling the scent of the sweet treat.After several tests and a biopsy, the dad-of-four was diagnosed with stage 4 IDH-wildtype glioblastoma—the most aggressive type of brain cancer—in April 2024.Costas’ son, Antonio, 27, a quantity surveyor, from Stoke-on-Trent, said: ‘All of our lives have just been flipped upside down.’His sense…
Soaring car insurance premiums are ‘outside of firms’ control’ rather than being driven by insurer profits, the City regulator has said. The Financial Conduct Authority found that the cost of motor claims has been primarily driven by higher prices for cars, parts, labour and energy.The cost of hire vehicles, and the number and cost of theft claims, and uninsured drivers have also contributed to the rise.The average cost of car insurance premiums dropped 7 per cent in the first three months of 2025 compared to a year earlier, from £635 to £539, according to figures from the Association of British Insurers.However,…
A small business insurance policy doesn’t need to be expensive. The exact price you’ll pay depends on a number of factors, including: Your business operations (high-risk vs. low-risk operations). What type of coverage you buy. The insurance provider you choose. How much you’re willing to pay out of pocket after an accident or mistake. NEXT shares what goes into what most small businesses pay for business insurance and how companies can save. What Affects The Cost Of Business Insurance For A Small Business? Small business owners’ insurance is often made up of different policies that provide protection for different risks. You…
A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s prostate cancer was recently labelled “aggressive” and described as having spread to his bones, many assumed the worst. Yet today, thanks to astonishing advances in cancer science, a stage-four label need not mean imminent death.“Stage four means the cancer has spread to another part of the body further away from where it started,” explains Dr Ben O’Leary, a clinical oncologist at the Royal Marsden and a researcher at The Institute of Cancer Research (ICR). “Most stage-four cancers…
Insurers have been told by the Financial Conduct Authority (FCA) to improve their claims handling, following “concerning” evidence of poor practices in some cases.The regulator said that, while rising motor insurance premiums are largely driven by external cost pressures, shortcomings persist in how some insurers handle claims.FCA analysis indicated that increases in the cost of motor claims – due to higher prices for cars, parts, labour, energy and more complex cars and supply chains – have contributed to premium increases.The cost of hire vehicles, the number and cost of theft claims and uninsured drivers have also risen significantly. This confirms…
Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding its marketing application for its lead asset, RP1, declining to approve it as part of a combination regimen for melanoma, a type of skin cancer. In January, the FDA granted priority review for the company’s Biologics License Application targeted at patients with advanced melanoma as a treatment in combination with nivolumab, marketed by Bristol Myers (BMY) as Opdivo. The BLA, backed mainly by data from the company’s IGNYTE trial, was granted a target action date of July 22. As reasons for…